Union Pharmacist results, Q2 2024
Net profit, assets, equity and cash flow for Q2 2024, against the same period a year earlier, from the published financial statements.
Net profit-245 thousandEGP · +91.7% vs the same period a year earlier
Total assets57.13 millionEGP · −4.6% vs the same period a year earlier
Shareholders' equity9.85 millionEGP · +13.2% vs the same period a year earlier
Operating cash flow-116 thousandEGP · −100.2% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q2 2024 was about -245 thousand EGP, up +91.7% from -2.94 million EGP in Q2 2023.
- Total assets at the end of Q2 2024 were about 57.13 million EGP, and shareholders' equity about 9.85 million EGP.
- Operating cash flow for Q2 2024 was negative at 116 thousand EGP.
Key lines against the same period a year earlier
This periodQ2 2023Change
Net profit-245 thousand-2.94 million+91.7%
Gross profit52.65 thousand1.44 million−96.3%
Total assets57.13 million59.91 million−4.6%
Total liabilities47.28 million51.21 million−7.7%
Shareholders' equity9.85 million8.7 million+13.2%
Total liabilities and equity57.13 million59.91 million−4.6%
Operating cash flow-116 thousand47.28 million−100.2%
Investing cash flow-21 thousand——
Net change in cash-137 thousand47.28 million−100.3%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy